{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T07:00:33Z","timestamp":1768806033111,"version":"3.49.0"},"reference-count":21,"publisher":"Bentham Science Publishers Ltd.","issue":"1","license":[{"start":{"date-parts":[[2013,7,12]],"date-time":"2013-07-12T00:00:00Z","timestamp":1373587200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["clinical-practice-and-epidemiology-in-mental-health.com","benthamopen.com"],"crossmark-restriction":true},"short-container-title":["CPEMH"],"published-print":{"date-parts":[[2013,7,12]]},"abstract":"<jats:p>This paper proposes that a certain premorbid personality type \u2013 that of hard driving, achievement-oriented, often exercise-oriented individuals \u2013 correlates with bupropion response; conversely, patients without these premorbid traits and whose depression is marked by mood swings, irritability and rumination are likely fluoxetine responders. <\/jats:p>\n                <jats:p>The authors developed the Fluoxetine Bupropion Assessment Scale (FBAS), a 10-question, self-administered rating scale, to assess these traits and hypothesized that its use would improve outcomes. <\/jats:p>\n                <jats:p>A Marriage and Family Therapist (MFT) and a Registered Nurse\/Nurse Practitioner (RN\/NP) retrospectively reviewed 72 charts from one psychiatrist\u2019s office for two time periods: before and after the psychiatrist utilized the questionnaire to guide antidepressant selection (33 charts before and 39 charts after). Raters were blinded to the theory and to the treatment time period. On the basis of clinical information in the charts, they formulated Clinical Global Impression assessments of treatment response in patients with Beck Depression Inventory scores \u226517 who were not on either drug at the time of intake, and who were prescribed either fluoxetine or bupropion.<\/jats:p>\n                <jats:p>The data were in the direction of better results in the FBAS-guided group, particularly after adjusting for age, gender and marital status (efficacy p = 0.087). When global improvement data were combined into three groups describing treatment response (improved, minimal to no improvement, and worse) there were statistically significant better results (p = 0.047) in the FBAS-guided treatment group. Revision and validation of the questionnaire and a larger, randomized study seem indicated.\n<\/jats:p>","DOI":"10.2174\/1745017901309010142","type":"journal-article","created":{"date-parts":[[2013,7,30]],"date-time":"2013-07-30T00:55:35Z","timestamp":1375145735000},"page":"142-147","update-policy":"https:\/\/doi.org\/10.2174\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Which Drug For Which Patient? Is There a Fluoxetine Responding Versus a Bupropion Responding Personality Profile?"],"prefix":"10.2174","volume":"9","author":[{"given":"D. Stewart","family":"Bell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Mark","family":"Shipman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario A.","family":"Cleves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill","family":"Siegelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"refR1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-1781(89)90192-3","volume":"28","author":"Georgotas A","year":"1989","unstructured":"Georgotas A, McCue RE, Cooper TB, Nagachandran N, Friedhoff A. \n                    Factors affecting the delay of antidepressant effect in responders to nortriptyline and phenelzine \n                    Psychiatry Res  \n                    1989; \n                    28\n                    (1)\n                    : 1-9.","journal-title":"Psychiatry Res"},{"key":"refR2","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1176\/ajp.151.9.1372","volume":"151","author":"Fava M","year":"1994","unstructured":"Fava M, Rosenbaum JF, McGrath PJ, Stewart JW, Amsterdam JD, Quitkin FM. \n                    Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled\nstudy \n                    Am J Psychiatry  \n                    1994; \n                    151\n                    (9)\n                    : 1372-4.","journal-title":"Am J Psychiatry"},{"key":"refR3","volume":"55","author":"Nemeroff CB","year":"1994","unstructured":"Nemeroff CB. \n                    Evolutionary trends in the pharmacotherapeutic management of depression \n                    J Clin Psychiatry [Review]  \n                    1994; \n                    55\n                    (Suppl 3-15)\n                    \n                 discussion 6-7","journal-title":"J Clin Psychiatry [Review]"},{"key":"refR4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1176\/appi.ajp.163.1.28","volume":"163","author":"Trivedi MH","year":"2006","unstructured":"Trivedi MH, Rush AJ, Wisniewski SR, et al. \n                    Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice \n                    Am J Psychiatry  \n                    2006; \n                    163\n                    (1)\n                    : 28-40.","journal-title":"Am J Psychiatry"},{"key":"refR5","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1136\/bmj.318.7192.1188","volume":"318","author":"Spigset O","year":"1999 1","unstructured":"Spigset O, Martensson B. \n                    Fortnightly review: drug treatment of depression \n                    BMJ [Review]  \n                    1999 1; \n                    318\n                    (7192)\n                    : 1188-91.","journal-title":"BMJ [Review]"},{"key":"refR6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/026988110001400101","volume":"14","author":"Anderson IM","year":"2000","unstructured":"Anderson IM, Nutt DJ, Deakin JF. \n                    Evidence-based guidelines for\ntreating depressive disorders with antidepressants: a revision of the\n1993 British Association for Psychopharmacology guidelines.\nBritish Association for Psychopharmacology \n                    J Psychopharmacol  \n                    2000; \n                    14\n                    (1)\n                    : 3-20.","journal-title":"J Psychopharmacol"},{"key":"refR7","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1192\/bjp.bp.105.010470","volume":"188","author":"Wijkstra J","year":"2006","unstructured":"Wijkstra J, Lijmer J, Balk FJ, Geddes JR, Nolen WA. \n                    Pharmacological treatment for unipolar psychotic depression: Systematic review and meta-analysis \n                    Br J Psychiatry  \n                    2006; \n                    188\n                    : 410-5.","journal-title":"Br J Psychiatry"},{"key":"refR8","first-page":"25","volume":"59","author":"Davidson JR","year":"1998","unstructured":"Davidson JR, Connor KM. \n                    Bupropion sustained release: a therapeutic overview \n                    J Clin Psychiatry [Review]  \n                    1998; \n                    59\n                    (Suppl 4)\n                    : 25-31.","journal-title":"J Clin Psychiatry [Review]"},{"key":"refR9","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/S0149-2918(97)80066-5","volume":"19","author":"Stokes PE","year":"1997","unstructured":"Stokes PE, Holtz A. \n                    Fluoxetine tenth anniversary update: the progress continues \n                    Clin Ther  \n                    1997; \n                    19\n                    (5)\n                    : 1135-250.","journal-title":"Clin Ther"},{"key":"refR10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1089\/cap.1997.7.87","volume":"7","author":"Riggs PD","year":"1997","unstructured":"Riggs PD, Mikulich SK, Coffman LM, Crowley TJ. \n                    Fluoxetine in drug-dependent delinquents with major depression: an open trial \n                    J Child Adolesc Psychopharmacol  \n                    1997; \n                    7\n                    (2)\n                    : 87-95.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"refR11","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0193-953X(05)70290-2","volume":"19","author":"Nunes EV","year":"1996","unstructured":"Nunes EV, Deliyannides D, Donovan S, McGrath PJ. \n                    The management of treatment resistance in depressed patients with substance use disorders \n                    Psychiatr Clin North Am  \n                    1996; \n                    19\n                    (2)\n                    : 311-27.","journal-title":"Psychiatr Clin North Am"},{"key":"refR12","first-page":"68","volume":"23","author":"Akiskal HS","year":"1987","unstructured":"Akiskal HS, Mallya G. \n                    Criteria for the \"soft\" bipolar spectrum: treatment implications \n                    Psychopharmacol Bull  \n                    1987; \n                    23\n                    (1)\n                    : 68-73.","journal-title":"Psychopharmacol Bull"},{"key":"refR13","first-page":"46","volume":"55","author":"Akiskal HS","year":"1994","unstructured":"Akiskal HS. \n                    Dysthymic and cyclothymic depressions: therapeutic considerations \n                    J Clin Psychiatry [Review]  \n                    1994; \n                    55\n                    (Suppl)\n                    : 46-52.","journal-title":"J Clin Psychiatry [Review]"},{"key":"refR14","unstructured":"Mendelson M, Freeman AM, Kaplan HI. \n                    Neurotic depressive\nreactions. \n                    Baltimore: Williams and Wilkins Co 1967."},{"key":"refR15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/070674379403900106","volume":"39","author":"Ravindran AV","year":"1994","unstructured":"Ravindran AV, Bialik RJ, Lapierre YD. \n                    Therapeutic efficacy of specific serotonin reuptake inhibitors (SSRIs) in dysthymia \n                    Can J\nPsychiatry  \n                    1994; \n                    39\n                    (1)\n                    : 21-6.","journal-title":"Can J\nPsychiatry"},{"key":"refR16","unstructured":"Kramer PD. \n                    Listening to Prozac. \n                    New York: Penguin Book 1993."},{"key":"refR17","unstructured":"The American Psychiatric Association. \n                    Diagnostic and Statistical\nManual of Mental Disorders.  4th ed. \n                    Washington: American\nPsychiatric Press 1994."},{"key":"refR18","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.pbb.2007.11.007","volume":"89","author":"McMorris T","year":"2008","unstructured":"McMorris T, Collard K, Corbett J, Dicks M, Swain JP. \n                    A test of the catecholamines hypothesis for an acute exercise-cognition interaction \n                    Pharmacol Biochem Behav  \n                    2008; \n                    89\n                    (1)\n                    : 106-5.","journal-title":"Pharmacol Biochem Behav"},{"key":"refR19","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1177\/070674378603100617","volume":"31","author":"Simeon JG","year":"1986","unstructured":"Simeon JG, Ferguson HB, Van Wyck Fleet J. \n                    Bupropion effects in attention deficit and conduct disorders \n                    Can J Psychiatry  \n                    1986; \n                    31\n                    (6)\n                    : 581-.","journal-title":"Can J Psychiatry"},{"key":"refR20","first-page":"120","volume":"23","author":"Casat CD","year":"1987","unstructured":"Casat CD, Pleasants DZ, Van Wyck Fleet J. \n                    A double-blind trial of bupropion in children with attention deficit disorder \n                    Psychopharmacol Bull  \n                    1987; \n                    23\n                    (1)\n                    : 120-2.","journal-title":"Psychopharmacol Bull"},{"key":"refR21","doi-asserted-by":"crossref","unstructured":"Hosmer DW, Lemeshow S. \n                    Applied logistic regression. \n                    USA: Wiley 2000.","DOI":"10.1002\/0471722146"}],"container-title":["Clinical Practice &amp; Epidemiology in Mental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/clinical-practice-and-epidemiology-in-mental-health.com\/contents\/volumes\/V9\/CPEMH-9-142\/CPEMH-9-142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/clinical-practice-and-epidemiology-in-mental-health.com\/contents\/volumes\/V9\/CPEMH-9-142\/CPEMH-9-142.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/clinical-practice-and-epidemiology-in-mental-health.com\/contents\/volumes\/V9\/CPEMH-9-142\/CPEMH-9-142.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T02:28:52Z","timestamp":1554344932000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinical-practice-and-epidemiology-in-mental-health.com\/VOLUME\/9\/PAGE\/142\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,12]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7,12]]}},"alternative-id":["CPEMH-9-142"],"URL":"https:\/\/doi.org\/10.2174\/1745017901309010142","relation":{},"ISSN":["1745-0179"],"issn-type":[{"value":"1745-0179","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2013-2-3","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-5-18","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-5-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2013-7-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}